CYTO   $0.58  -1.69% Market Closed

Altamira Therapeutics Ltd
Total Cash 65.45K
totalCashPerShare 0.025
EBITDA
Total Debt 427.44K
quickRatio 0.152
currentRatio 0.427
Total Revenue
debtToEquity 6.765
Revenue/Share
ROA -0.57145
ROE -3.68779
grossProfits
freeCashflow -5.41M
operatingCashflow -7.58M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.94M
forwardPE -0.426
floatShares 2.65M
sharesOutstanding 3.78M
sharesShort 23.59K
sharesShortPriorMonth 180.20K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.30%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.366
Price To Book help_outline 0.24
earningsQuarterlyGrowth
netIncomeToCommon -7.91M
trailingEps 1.82%
forwardEps -1.35%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 5
lastUpdated Oct. 22, 2024, 12:50 a.m.